(Total Views: 84)
Posted On: 10/26/2020 1:03:02 PM
Post# of 41733
![Avatar](https://investorshangout.com/images/ProfileImages/734810790_1098_wst.png)
$PBIO Company Locks-in Final Design Specifications, Begins Initial Build of Proprietary Ultra Shear Technology System, & Remains on Target for Commercial Release by Early 2021
SOUTH EASTON, Mass., Oct. 6, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, today announced the achievement of a critical milestone: the lock-in of final design specifications for the commercial production model of its proprietary, next-generation Ultra Shear Technology™ ("UST™"
-based nanoemulsification system. Following achievement of this milestone, the Company has begun to build the initial "Alpha" unit of the commercial model. Once built, tested, and approved, the Company will immediately proceed to build an additional 15 ready-for-sale systems, thus enabling PBI to meet its goal of shipping the BaroShear K45 UST System in early (Q1/Q2) 2021.
SOUTH EASTON, Mass., Oct. 6, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
![](/m/images/icons/icon_wink.gif)
![](/m/images/icons/icon_wink.gif)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)